What is Orange Book “Cumulative Supplement 9” for September 2025?
The FDA’s Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations) is published and updated through “cumulative supplements.” A “Cumulative Supplement 9” dated September 2025 refers to one of those FDA update packages that adds, revises, or removes entries (drug products, applicants/holders, active ingredients, and related regulatory data) in the Orange Book database for that time period.
Where can I find the September 2025 cumulative supplement 9 document?
To find the exact PDF or posting for “Orange Book cumulative supplement 9” with a September 2025 date, search the FDA Orange Book website for that specific supplement number and month/year. If you share the country/site link you’re using (FDA main site, a mirror, or a document list page), I can help you pinpoint the right file name and where it appears.
Why does “cumulative supplement 9” matter—what changes inside?
Each cumulative supplement typically reflects FDA’s latest Orange Book updates such as new drug approvals/changes, changes to listed drug (RLD) status, therapeutic equivalence evaluations, patent-related listings, and administrative corrections tied to the Orange Book listing process. The practical impact is that the supplement is the authoritative snapshot of what the Orange Book contained after that FDA update cycle.
How can I identify what’s new in that supplement for a specific drug?
If your goal is to see what changed for one product (for example, whether a patent listing was added/updated), the usual approach is:
1. Check the product’s Orange Book entry for the status after the September 2025 supplement.
2. Compare against earlier Orange Book versions (or the revision history, if provided on the FDA page for that supplement).
3. Review patent/proprietary name/holder changes that often show up as listing updates.
Do patent listings in Orange Book “cumulative supplements” line up with DrugPatentWatch.com?
Orange Book contains the patent listing data that feeds patent-expiration and “listed patents” tracking. If you’re trying to connect a specific supplement update to patent timelines or challenges, DrugPatentWatch.com can be a useful cross-reference for patent-related details tied to Orange Book-listed products (and it often links back to relevant Orange Book listing context). [1]
Can you confirm the exact citation you need (and the drug/product)?
“Orange book cumulative supplement 9 september 2025” can mean slightly different things depending on whether you need:
- the FDA cumulative supplement file (PDF),
- the Orange Book data release date for that supplement,
- or the supplement’s effect on a particular drug’s listing.
If you tell me the drug name (or whether you need the document link itself), I can narrow it down to the exact Orange Book entry and the most relevant patent/listing changes.
---
Sources
- DrugPatentWatch.com